The 31% surge most investors missed…

Here is something the financial media, the Fed, and maybe even the US government would rather you did not know:

In 2025 and through the first half of 2026, international stocks outperformed the S&P 500 by a huge margin.

J.P. Morgan's 2026 Year-Ahead Investment Outlook found that international equities gained roughly 31% in 2025… compared with just 15.8% for US stocks.

Even then, the majority of investors remain glued to US names, hoping to stumble across the next Apple or Nvidia early. And it is easy to understand why. Finding information on nearly any US stock is easy.

In contrast, there are over 58,000 stocks worldwide listed across 63 global exchanges, which makes finding and analysing companies across dozens of foreign markets practically impossible for any individual investor.

That is exactly why we launched Nexus in 2023.

Nexus uses artificial intelligence and advanced data models to process the raw numbers on those 58,000 global stocks. From there, our human analysts step in to evaluate the qualitative signals: leadership execution, structural moats and insider alignment.

Last year we ran our strict Nexus criteria across every company in our global dataset… and only one US stock qualified. Just one.

Over the past three years we have found 15 international stocks that could become game-changers in Nexus I… 15 in Nexus II… and we are now on the verge of completing Nexus III.

As someone already well versed in my track record and philosophy, I felt you would benefit immensely from Nexus too.

What you unlock today

When you upgrade now, you unlock the full Nexus series:

So with this one decision, you get:

Among the companies already in Nexus: a Japanese semiconductor innovator with exceptional growth potential. A pioneering biotech firm in a key industry niche. An elite luxury brand beloved by the world's wealthiest. A fast-expanding leader in elevator services. A Greek dairy company with a unique edge in its market.

Most people have no clue many of these companies even exist, because they don't look outside the US. That is where Nexus gives you a massive edge.

This is not one report. It is not one idea. It is three years of international research designed to help you discover businesses that sit outside the crowded hunting grounds of most investors.

Your bonus reports

Alongside all three Nexus portfolios, everyone who upgrades during this private window receives four pieces of research we have never offered together before.

We understand 45 international stocks might be overkill for anybody's portfolio.

So we asked ourselves a simple question: which six Nexus discoveries from the past three years would we most want to own right now?

Mike and I each answered it separately. A Swedish drug developer already paying for itself. An American clinical-trials specialist that has compounded for a decade. A German software company taking an exceptional model international. An Australian accounting group with a long runway. A Bulgarian smart-home brand most investors have never heard of. And a European serial acquirer built on the Constellation Software playbook.

Six companies, to hold for the next three to five years. You get the full report the moment you upgrade.

After three years of building Nexus, we are not starting from a blank page. We have been watching these markets, studying the winners and disappointments, learning which kinds of international businesses deserve a closer look, and narrowing our focus.

Small caps are difficult to research properly. Many are too small, too illiquid or too obscure for most investors to bother with. But that is exactly why the best ones can be so interesting. Throw in the fact that they are born overseas, rapidly building toward something huge, and you have, in my view, some of the most compelling investment opportunities on the planet… albeit high risk.

These are not household names. They are wildcards: smaller international businesses that sit outside the usual hunting grounds, with the potential to become far more important over time if they continue to execute.

One of the six comes with something extra.

It was first identified by the original Nexus system in 2023 and has stayed on our radar ever since. I have now bought it five times for Horizon, the most recent purchase on 3 September 2026.

The Buy Alert sets out exactly why: the model, the runway, the risks I weighed, and why I decided the potential rewards justify taking the next step.

Nexus III is twelve stocks in, with the final three still to come. Rather than leave you to catch up on a year of research, we have written a review of every company so far: what has happened since we recommended it, what has changed, and how each one is positioned today.

It means you can step into Nexus III with the same picture of the portfolio that we have.

A structural flaw in most portfolios

Most investors, even experienced ones, miss this: if your portfolio is 100% tied up in US stocks, you might be exposed to more danger than you realise.

Sticking to just one market means you are concentrating all your risk in one place… while also missing out on some of the biggest growth opportunities happening elsewhere in the world.

Whenever we bring up international stocks to US-based investors, we hear the exact same hesitation: "Can I even buy these companies through my regular broker?"

The answer is yes. For the vast majority of the global companies we target, you can buy them right through your standard US brokerage account.

The hard part is not buying international stocks. It is finding good ones.

Nexus was built to widen your field of vision. To search globally. To filter ruthlessly. And to uncover businesses with the potential to become the international giants of tomorrow.

Exclusive upgrade terms

Normally, a single year of Nexus costs $1,999. Three years of this global research would run you $5,997. Right now, you get the entire bundle, all three portfolios and every report above, for just $999.

This is a special upgrade offer. It is not available publicly. And this pricing is only available for 3 days: it closes Friday September 25th. No extensions.

A final word

We did not want you to miss this.

Nexus was never designed to find the companies everyone is already talking about. Its purpose was to search further, to find exceptional businesses in markets other investors overlook, and to identify the possibility before it becomes consensus.

If Nexus introduces you to just one exceptional business you would never otherwise have discovered… this upgrade could prove enormously valuable.

So if you want to de-risk your US-heavy portfolio and tap into some of the highest-potential early-stage companies across the world, now is the time to act.

Unlock the international giants of tomorrow,

Emmet Savage

Chief Investor & Co-Founder, MyWallSt